New weight loss pill approved for use in UK

Eli Lilly’s Foundayo, a daily weight-loss pill and GLP-1 medication, has received UK approval, becoming the first such treatment authorized in Europe. It treats obesity and type 2 diabetes but requires separate NHS approval for weight-loss coverage.